News 
Market Data 
Discover
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Nice share structure here, this can move big!
$LBTD
$LBTD Facilitating Services for Netflix, Amazon Prime, HBO, CBS, Discovery, NBC; Lotus Bio-Technology: Stock Symbol LBTD Lotus Bio-Technology Development Corp. (OTCMKTS: LBTD) Acquisition and Expansion Plans of Focal Point Healthcare, a CLIA-Authorized Lab for $LBTD https://www.einpresswire.com/article/610474819/facilitating-services-for-netflix-amazon-prime-hbo-cbs-discovery-nbc-lotus-bio-technology-stock-symbol-lbtd
$LBTD .034's up early!
View LBTD’s complete portfolio:
https://www.lotusbioholdings.com/holdings
Watching for more announcements in 2023 regarding the company’s updated holdings $LBTD
LBTD is getting some good media attention now for the company's role in keeping a lot of workforces running more safely in the pandemic era. The big name entertainment industry clients who are using LBTD Covid testing services are especially encouraging to see. These companies have a lot of money at stake which depends on keeping their productions on schedule. Readily available and reliable Covid testing is a very important part of that.
.03's coming!
$LBTD
Time to load up!
$LBTD
$LBTD low float play here, expecting a huge 2023 !
A steal at these levels, oversold here .039 up!
$LBTD
LBTD Focal Point Healthcare Services has partnered with a number of businesses, professional sports teams, and facilities. LBTD has streamlined the process of collecting hundreds of samples and getting results in a timely manner. LBTD understands the importance and urgency of administering testing to our corporate accounts to ensure all employees are safe and healthy. LBTD offers flexible dates and times for service.
$LBTD Acquisition and Expansion Plans of Focal Point Healthcare, a CLIA-Authorized Lab for $LBTD; Facilitating Services for Netflix, Amazon Prime, HBO, CBS, Discovery
Lotus Bio-Technology Development Corp. (OTCMKTS: LBTD)
We have a remarkable business with incredible revenue & an extremely competent management team. We have carefully designed our business in such a way that we feel confident success is our only option”— LBTD President Hoyt ChristopherCAVE CREEK, ARIZONA, UNITED STATES, January 10, 2023 /EINPresswire.com/ -- Acquisition and Expansion Plans of Focal Point Healthcare, a CLIA-Authorized Lab for $LBTD; Facilitating Services for Netflix, Amazon Prime, HBO, CBS, Discovery, NBC’s Peacock, Autozone + More: Lotus Bio-Technology: (Stock Symbol LBTD)
? Digital Healthcare Company Focused on Covid Testing Services for Important Wide Client Base.
? New Management with Expansive Vision for 2023 and Beyond.
? Nationwide Mobile Covid Testing Services for Business, School, Pre-Flight, and Other Key Safety Needs.
? Focused on Acquiring and Developing Companies and Technology that Emphasize a User-Friendly Approach.
? Leadership Team Represents a Unique Blend of Entertainment and Medical Professionals who came out of COVID-19 Testing for TV and Film Productions.
? Subsidiary Focal Point’s Revenue From Medical Testing Exceeds 13 Million for 2021 and 2022.
Lotus Bio-Technology Development Corp. (OTC: LBTD) is committed to improving healthcare and advancing diagnostics through technology development and market acquisition. LBTD currently manages a portfolio of state-of-the-art technologies and innovative companies that are successfully modernizing medicine and prioritizing a user-friendly approach to patient care.
LBTD Subsidiary Focal Point Healthcare offers a nationwide range of mobile Covid Testing which can be sent out within 24 hours of notice. LBTD has already established multiple locations of operation in California, Arizona, Nevada, and Florida. Current services include the following:
Drive-Thru Testing
LBTD Drive Thru testing does not require an appointment. LBTD offers two types of tests, a Rapid Antibody test (finger prick) and a PCR (nasal swab).
A licensed clinician performs the Rapid Antibody test (finger prick), and has it interpreted by a LBTD Medical Director. The results will be sent via email to you within 30-45 minutes.
The PCR test (nasal swab) is performed by a licensed clinician and the specimen will be sent to one of the company’s laboratories. Results take 24-48 hours to be sent out via email.
School Districts
Board Certified in Pathology Medical Director.
On-the-ground, experienced production representative to establish a testing base camp and implement protocols at each studio or location.
LBTD Focal Point Health Care owns multiple labs to ensure quick results & fast turn-around to keep productions on time and on budget.
LBTD labs and testing services are licensed in all 50 US States & Canada and have been granted Emergency Use Authorization (EAU) by the FDA for SARS-CoV-2 tests.
Preflight Testing
LBTD Focal Point Healthcare Services has partnered with a number of airlines and airports which require preflight Covid testing. By guaranteeing a timely turnaround time, LBTD makes sure that all customers are ready in time for their flights. Results can be sent directly to the customer to bring to the airport.
Corporate Partnerships
LBTD Focal Point Healthcare Services has partnered with a number of businesses, professional sports teams, and facilities. LBTD has streamlined the process of collecting hundreds of samples and getting results in a timely manner. LBTD understands the importance and urgency of administering testing to our corporate accounts to ensure all employees are safe and healthy. LBTD offers flexible dates and times for service.
With LBTD management having experience and key connections in the entertainment field, the company has been performing important testing services to keep some very high-profile shows running safely and on a timely basis.
The notable list of entertainment products that LBTD has tested for:
Netflix
My Unorthodox Life
Bling Empire LA
Bling Empire NYC
Amazon
Tampa Baes
CBS/VIACOM
Bar Rescue
Discovery
Ghost Town
Revolt
Michelle Obama Special
DISCLAIMER: CAP/FrontPageStocks/CorporateAds.com (CA) is a third-party publisher and news dissemination service provider. CAP/FPS/CA is NOT affiliated in any manner with any company mentioned herein. CAP/FPS/CA is a news dissemination solutions provider and is NOT a registered broker/dealer/analyst/adviser, holds no investment licenses, and may NOT sell, offer to sell or offer to buy any security. CAP/FPS/CA’s market updates, news alerts, and corporate profiles are NOT a solicitation or recommendation to buy, sell or hold securities. The material in this release is intended to be strictly informational and is NEVER to be construed or interpreted as research material. All readers are strongly urged to perform research and due diligence on their own and consult a licensed financial professional before considering any level of investing in stocks. All material included herein is republished content and details which were previously disseminated by the companies mentioned in this release or the opinion of the writer. CAP/FPS/ CA is not liable for any investment decisions by its readers or subscribers. Investors are cautioned that they may lose all or a portion of their investment when investing in stocks. CAP/FPS/CA has been compensated $500 by a third party for the dissemination of this article.
Disclaimer/Safe Harbor:
These news releases and postings may contain forward-looking statements within the meaning of the Securities Litigation Reform Act. The statements reflect the Company’s current views with respect to future events that involve risks and uncertainties. Among others, these risks include the expectation that any of the companies mentioned herein will achieve significant sales, the failure to meet schedule or performance requirements of the companies’ contracts, the companies’ liquidity position, the companies’ ability to obtain new contracts, the emergence of competitors with greater financial resources and the impact of competitive pricing. In light of these uncertainties, the forward-looking events referred to in this release might not occur.
SOURCE: CorporateAds.com
Hoyt Christopher, CEO
Lotus Bio-Technology Development Corp.
+1 778-814-7729
email us here
Visit us on social media:
Instagram: https://www.instagram.com/lbtdholdings/
$LBTD check it out: Facilitating Services for Netflix, Amazon Prime, HBO, CBS, Discovery, NBC; Lotus Bio-Technology: Stock Symbol LBTD https://www.einpresswire.com/article/610474819/facilitating-services-for-netflix-amazon-prime-hbo-cbs-discovery-nbc-lotus-bio-technology-stock-symbol-lbtd
A great setup here with this share structure, calm before the storm, big bull run coming this year.
$LBTD
$LBTD believes that by combining the resources of acquired companies, it will be able to quickly expand activity, reach, and production.
Yeah watching for news, great levels to add though.
$LBTD
$LBTD low floater here, going to be a huge 2023 for the company!
$LBTD Lotus Bio-Technology Development to make formal announcements in early 2023 regarding ownership, management and the company’s updated holdings
https://lnkd.in/gUeTMvu7
$LBTD +34.76% nice push to end the week!
I do like how LBTD moves up with a little attention. Investors are seeing that Covid is not going away anytime soon no matter how well we vaccinate. It will continue to be vital to have effective and available Covid testing services to keep our society running with a level of safety and confidence that we can rely upon. LBTD is playing a key role to achieve this goal and the business plan here should have plenty of work to fulfill for years to come.
$LBTD thin to .05's!
+38.04% closing strong!
$LBTD
The LBTD Focal Point Healthcare operation has great capabilities to serve the needs of businesses, transportation, educational institutions and others with rapid response Covid testing. This is a very valuable option that can keep all kinds of activities on track with the safety for everyone involved being protected during the ongoing pandemic.
See all the services available here: https://focalpointhealthcare.com/
$LBTD +18.32% .043 ready to fall!
$LBTD BioGnomics provides access to COVID-19 PCR test kits through an at-home medical testing brand called Boomerang. Click the button below to visit Boomerang’s website. https://boomerangkit.com/
$LBTD Sale of at-home diagnostic testing brand reflects corresponding leadership changes with new director appointment "Lotus Bio-Technology Development Corp. announces sale of Boomerangkit.com, LLC"
https://www.marketwatch.com/press-release/lotus-bio-technology-development-corp-announces-sale-of-boomerangkitcom-llc-2022-10-25?mod=mw_quote_news_seemore
LBTD put a lot of development effort into their Boomerang platform to serve a wide range of people with the best and most efficient healthcare testing. The company's successful sale of this asset, as recently announced, validates the capabilities of the LBTD development team.
----------------------------------------------------------------------------------------------------------------
Boomerang is an At-home, digital health testing corporation supporting women's health, men's health, dietary health and sexual health. Boomerang delivers a series of at-home diagnostic tests that help form a complete picture of their current overall health including hormone levels, allergies, sensitivities, and any pre-existing conditions or infections. Then, based on those results, and a user's unique interests, lifestyle and goals, an advisor from Boomerang works with the individual one on one to help customize a wellness plan that incentivizes them to continue caring for their health and reach new goals. Through innovative at-home diagnostic testing, customizable wellness plans, and strategic partnerships, Boomerang can provide unparalleled access to healthcare and improve quality of life for its users.
.04's could hit quick!
$LBTD
|
Followers
|
27
|
Posters
|
|
|
Posts (Today)
|
0
|
Posts (Total)
|
1370
|
|
Created
|
07/08/13
|
Type
|
Free
|
| Moderators | |||
